← Back to Clinical Trials
Recruiting NCT06962605

NCT06962605 Effects of Intermittent Running on Metabolic Health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06962605
Status Recruiting
Phase
Sponsor National Taiwan Normal University
Condition Metabolic Regulation
Study Type INTERVENTIONAL
Enrollment 16 participants
Start Date 2025-06-21
Primary Completion 2026-04-30

Eligibility & Interventions

Sex Male only
Min Age 20 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Moderate-intensity continuous running (MICE: 60% V̇O2max)5-minute interval running (5MIN)2-minute interval running (2MIN)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 16 participants in total. It began in 2025-06-21 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to investigate the suitability of intermittent exercise of long and short intervals at lower intensities than HIIE on energy expenditure during and post-exercise compared to MICE, as well as determine whether similar or greater effects can be achieved for glycemic control in recreationally active adults.

Eligibility Criteria

Inclusion Criteria: * Healthy recreationally active men * BMI between 18.5-27 kg/m2 * Aged between 20 to 45 years * Regular exercise (3 times per week and longer than 3 months) with cardio exercise longer than 30 minutes at least once a week * Weight stable for more than 3 months (no change in weight +/- 3%) * Non-shift workers and sleep at least 6.5-9 hours for the past 3 months * Non-smoker Exclusion Criteria: * having any cardiovascular, metabolic or pulmonary disease (angina pectoris or uncontrolled arrhythmias) * suffering from infectious contagious diseases, * using medications that could affect metabolic responses (including anti-inflammatory medications) * smoking * heavy alcohol intake (more than 4 drinks on any day or more than 14 drinks a week). * undergoing special diets (e.g., intermittent fasting and/or ketogenic diets)

Contact & Investigator

Central Contact

Yung-Chih Chen, PhD

✉ yc.chen@ntnu.edu.tw

📞 +886277496979

Frequently Asked Questions

Who can join the NCT06962605 clinical trial?

This trial is open to male participants only, aged 20 Years or older, up to 45 Years, studying Metabolic Regulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06962605 currently recruiting?

Yes, NCT06962605 is actively recruiting participants. Contact the research team at yc.chen@ntnu.edu.tw for enrollment information.

Where is the NCT06962605 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT06962605 clinical trial?

NCT06962605 is sponsored by National Taiwan Normal University. The trial plans to enroll 16 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology